Uncategorized Archives - Page 8 of 248

TuesdayMay 14, 2024 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Partners with the National Research Council of Canada for DehydraTECH-GLP-1 Mode of Action Investigation

Lexaria, a global innovator in drug delivery platforms, just announced its newest relationship with the National Research Council of Canada (“NRC”) Specific molecular characteristics of the glucagon-peptide 1 (“GLP-1”) drug, semaglutide, processed with Lexaria’s patented DehydraTECH(TM) technology, will be evaluated Previous research has shown that using a DehydraTECH-semaglutide capsule composition yields a 43% higher peak level of semaglutide in blood compared to Rybelsus(R). This has potential for increased weight-loss and diabetic control Lexaria’s management is confident that this partnership will complement the company’s animal and human pharmacokinetic and pharmacodynamic studies for the 2024 calendar year Lexaria Bioscience (NASDAQ: LEXX), a…

MondayMay 13, 2024 12:45 pm

Illinois Cannabis Convention & Expo to Attract the Biggest Traders in the Cannabis Spectrum

The NECANN Illinois Cannabis Convention 7 Expo is being held May 31 – June 1, 2024, at the Schaumburg Convention Center, Chicago, IL. One of the biggest cannabis B2B conventions in the country, the event will witness prominent growers, traders, enthusiasts, patients, educators, dealers, and top industry leaders. Newcomers as well as seasoned businesses can showcase their products or unique ideas at the exhibitor booths to gain visibility among the top investors, industries, and traders in the cannabis industry. The exhibitor booths significantly attract the crowds as they have fresh and innovative items on display. Operating since 2014, NECANN events…

FridayMay 10, 2024 4:20 pm

420 with CNW — Reports Confirm DEA Is Close to Reclassifying Marijuana

The U.S. Drug Enforcement Administration (DEA) is set to change the classification of cannabis. The proposal, pending review by the White House Office of Management and Budget (OMB), acknowledges marijuana’s medical potential and implies that it is less prone to abuse compared to other certain drugs. However, it does not advocate for the complete legalization of marijuana for recreational purposes. The move, disclosed by anonymous sources familiar with the matter, signals a major policy change for the DEA and a shift in U.S. drug policy. Once approved, the agency will invite public feedback on moving cannabis from Schedule I to…

ThursdayMay 09, 2024 12:00 pm

CannaCon West Albuquerque to Unite the Southwest Cannabis Industry

Traders, cannabis stakeholders, license holders, physicians, patients, regulatory authorities, entrepreneurs, capital investors, public officials, and enthusiasts, are invited to attend the CannaCon West Albuquerque at the Albuquerque Convention Center on May 17-18, 2024. The event focuses on bringing together all participants in the cannabis industry for two days of intense exploration, interaction, learning, and collaboration. As Albuquerque is witnessing an evolving cannabis industry, this event provides a phenomenal platform for cannabis veterans and newcomers to build a solid new industry. The CannaCon West Albuquerque is engaged in boosting the West’s cannabis industry. The Albuquerque network consists of like-minded cannabis businesses…

ThursdayMay 09, 2024 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Set to Extend Operational Runway to 2025 Following Warrant Exercise and Issuance

Lexaria has entered an agreement wherein an existing accredited investor has exercised all their warrants to purchase shares The company has received $4.7 million from this undertaking, prior to deducting estimated offering expenses Proceeds fully fund Lexaria’s entire planned 2024 GLP-1 R&D program, leaving additional excess capital for general purposes Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just announced its entry into a warrant exercise agreement with an existing accredited investor to exercise in full certain existing warrants initially issued in October 2023 and February 2024. The warrants will be exercised at $0.97 and $2.185 per…

WednesdayMay 08, 2024 10:30 am

Zoned Properties Inc. (ZDPY) Emerges as a Crucial Partner for the Cannabis Industry; Announced Planned $1 Million Share Buyback

Cannabis retail dispensaries in Arizona have grown to upwards of 168 locations as of January 2024 Nonetheless, only 1% of Arizona’s commercial properties are eligible for use by the cannabis industry Zoned Properties has been a key partner for the industry in helping cannabis companies establish a physical retail presence The company has recently announced the approval of a $1 million share buyback plan The legalized sale of recreational cannabis in Arizona has grown from strength to strength. Possession and cultivation of cannabis across the state became legal on November 30, 2020, with the state-licensed sale of recreational cannabis commencing…

TuesdayMay 07, 2024 11:15 am

Golden Triangle Ventures Inc. (GTVH) New Acquisition Takes Lavish Division One Step Closer to Development of Premier Music, Art Destination

More than half of Americans have attended a music festival, indicating lucrative potential for music and art destinations GTVH recently closed on the acquisition of ABI Create, a premier event-management and production company With the invaluable resources ABI Create brings to the table, the future of Destino Ranch looks more promising than ever With Coachella still fresh in music lovers’ memories, it’s only natural to look at what other amazing music festivals might be looming in the future. Destino Ranch comes to mind. A new project focused on becoming an international destination where nature and technology combine to create unforgettable…

TuesdayMay 07, 2024 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Targeting the Massive Type 2 Diabetes and Obesity Markets with its DehydraTECH(TM) Technology

Lexaria, a global innovator in drug delivery platforms, through its patented DehydraTECH(TM) technology, looks to address the growing type 2 diabetes and obesity problem Given the success of previous studies, the company is looking to double down on glucagon-like peptide 1 (“GLP-1”) studies for 2024 GLP-1 treatments are a major player in managing weight and addressing diabetes, and Lexaria’s DehydraTECH(TM) drug delivery platform has the potential of replacing painful and expensive GLP-1 injections with an effective oral delivery path The company has already received independent ethics review board approval for its GLP-1 human pilot study #2, a milestone that brings…

MondayMay 06, 2024 12:45 pm

BizCann Expo 2024 by ZJ Events, is Coming to Latin America

Date: May 18-19, 2024Venue: Plaza Mayor, Medellin Colombia ZJ Events brings BizCann Expo to Latin America, hosting the BizCann Expo 2024 in Medellin, Colombia, May 18-19, 2024. This event promises to boost cannabis investments and offer phenomenal cannabis business avenues in the region. The BizCann Expo 2024 conference offers cannabis traders, entrepreneurs, legislators, enthusiasts, and influencers, two days of networking, innovation, business, and education on the cannabis industry. The BizCann Expo 2024 is a premier event that will connect the leading American cannabis markets for better opportunities. It will boost cannabis trade by offering a networking platform to all the…

ThursdayMay 02, 2024 12:00 pm

BizCann Expo Brings Cannabis Business to Latin America

BizCann invites traders, vendors, entrepreneurs, regulatory authorities, investors, and cannabis enthusiasts, to attend the BizCann Expo being held in Medellin, Colombia, May 18-19, 2024. The BizCann Expo is organized by ZJ Events, bringing the businesses and professionals of the cannabis industry and its ancillaries to a common forum for networking, trading, and learning sessions. Having spread its reach over several cities in the US, BizCann Expo is being held in Medellin, Colombia, this year to offer phenomenal trading opportunities to local businesses. Due to its favorable location, connectivity, and rich history, Medellin offers the perfect venue for hosting this networking…